ArticleAging clinical and experimental research2025
Association of sarcopenia and pancreatic exocrine insufficiency in older adults type 2 diabetes mellitus patients.
Article in Aging clinical and experimental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
aimAn association between type 2 diabetes mellitus (T2DM) and pancreatic exocrine insufficiency (PEI) has been increasingly recognized. Sarcopenia is also common among older adults with T2DM, contributing to poor functional outcomes and increased frailty. Recent findings indicate a potential link between PEI and sarcopenia. The present study aimed to investigate the relationship between PEI and sarcopenia in older adults patients with T2DM, independent of other contributing factors.
methodsA total of 120 patients aged ≥ 65 years with T2DM were enrolled in the study. Demographic characteristics, diabetes-related clinical data, and malnutrition risk were assessed. Muscle strength, muscle mass, physical performance, and fecal elastase-1 levels were measured. Sarcopenia was diagnosed according to the criteria defined by the European Working Group on Sarcopenia in Older People 2 (EWGSOP2).
resultsPEI was present in 22.5% of patients, including 10% with severe and 12.5% with mild-to-moderate insufficiency Low muscle mass was observed in 15% of participants, while confirmed sarcopenia was identified in 10%. Patients with reduced hand grip strength exhibited significantly lower Mini Nutritional Assessment - Short Form (MNA-SF) scores and serum vitamin D levels; however, in male patients, only MNA-SF was significantly lower. The prevalence of PEI was significantly higher in males with probable sarcopenia compared to those without (34.8% vs. 10%, p = 0.05). In multivariate analysis among men, obesity showed a borderline significant association with probable sarcopenia, whereas PEI demonstrated a nonsignificant trend toward association. DISCUSSION AND
conclusionPEI may contribute to sarcopenia in older adults males with T2DM and should be considered in the clinical evaluation of sarcopenic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.